Targeting a master-regulator of inflammation with a monoclonal antibody potentially improves two unrelated conditions that currently have limited treatment options: preterm births and fatty liver disease, two new studies ...
Jun 22, 2023
0
81
Scientists investigating potential drugs to improve recovery from spinal cord injury have uncovered a promising route to new treatments.
Jun 19, 2023
0
44
Cytokines are proteins that help the human body to control and support the work of the immune system. Over the past few decades, a growing number of studies have been exploring the role of specific cytokines, including IL-12, ...
A new study led by Gonçalo Bernardes, group leader at the Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal) and Professor at the University of Cambridge (Cambridge, UK), published recently in the journal ...
Jan 20, 2023
0
78
A University of Cincinnati clinical trial that added an immunotherapy drug to standard of care treatment regimens has shown increased survival rates for head and neck cancer patients with intermediate risk features.
Mar 1, 2022
0
39
The newest vitamin B3 family member, nicotinamide riboside (NR) has been found to have beneficial effects on mitochondria in the human muscle. Currently, mitochondrial dysfunction cannot be treated. Recent findings from the ...
Feb 9, 2023
0
74
Breast cancer is the leading cause of cancer-associated death for women worldwide. While chemotherapy is the mainstream treatment for breast cancer, more than 50% of women undergoing chemotherapy will experience at least ...
May 3, 2022
0
77
A study conducted at the University of São Paulo (USP) in Brazil shows that the synthetic molecule Pep19 acts on the endocannabinoid system, which helps regulate and balance key metabolic functions, such as appetite, fat ...
Jul 5, 2022
0
31
University of California, Davis professor Bruce Hammock has spent a 50-year career studying insects. He probably wouldn't be the Ph.D. considered most likely to shake up the multibillion-dollar prescription painkiller market.
May 1, 2019
1
29
The experimental vaccine against SARS-CoV-2 that was the first to enter human trials in the United States has been shown to elicit neutralizing antibodies and a helpful T-cell response with the aid of a carefully engineered ...
Aug 5, 2020
0
182
